Ligand validation:3NB8

BLA: BILIVERDINE IX ALPHA

BLA is a Ligand Of Interest in 3NB8 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3NB8_BLA_A_249	95%	9%	0.068	0.97	2.56	1.99	11	12	0	0	100%	1
5B4J_BLA_A_301	98%	17%	0.055	0.981	2	1.61	10	5	0	0	100%	1
4EOC_BLA_A_1001	95%	8%	0.06	0.963	2.4	2.3	10	18	1	0	100%	0.9726
3I95_BLA_A_1130	93%	5%	0.067	0.963	2.85	2.48	10	20	0	0	100%	0.9884
3F0L_BLA_A_249	93%	25%	0.07	0.963	1.52	1.56	8	7	2	0	100%	1
5B4H_BLA_A_301	93%	20%	0.08	0.973	1.9	1.52	13	6	0	0	100%	1
5VIQ_BLA_A_401	95%	4%	0.067	0.97	2.99	2.59	16	21	1	0	100%	1
7E2S_BLA_A_301	94%	9%	0.063	0.962	2.91	1.56	18	7	0	0	100%	1
5F6Z_BLA_A_201	94%	3%	0.067	0.966	4.1	2	15	9	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.